Skip to main content
Journal cover image

Cognitive impairment as a target for pharmacological treatment in schizophrenia.

Publication ,  Journal Article
Davidson, M; Keefe, RS
Published in: Schizophr Res
September 1995

Duke Scholars

Published In

Schizophr Res

DOI

ISSN

0920-9964

Publication Date

September 1995

Volume

17

Issue

1

Start / End Page

123 / 129

Location

Netherlands

Related Subject Headings

  • Schizophrenic Psychology
  • Schizophrenia
  • Psychiatry
  • Nootropic Agents
  • Neuropsychological Tests
  • Humans
  • Cognition Disorders
  • Chronic Disease
  • Antipsychotic Agents
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Davidson, M., & Keefe, R. S. (1995). Cognitive impairment as a target for pharmacological treatment in schizophrenia. Schizophr Res, 17(1), 123–129. https://doi.org/10.1016/0920-9964(95)00037-m
Davidson, M., and R. S. Keefe. “Cognitive impairment as a target for pharmacological treatment in schizophrenia.Schizophr Res 17, no. 1 (September 1995): 123–29. https://doi.org/10.1016/0920-9964(95)00037-m.
Davidson M, Keefe RS. Cognitive impairment as a target for pharmacological treatment in schizophrenia. Schizophr Res. 1995 Sep;17(1):123–9.
Davidson, M., and R. S. Keefe. “Cognitive impairment as a target for pharmacological treatment in schizophrenia.Schizophr Res, vol. 17, no. 1, Sept. 1995, pp. 123–29. Pubmed, doi:10.1016/0920-9964(95)00037-m.
Davidson M, Keefe RS. Cognitive impairment as a target for pharmacological treatment in schizophrenia. Schizophr Res. 1995 Sep;17(1):123–129.
Journal cover image

Published In

Schizophr Res

DOI

ISSN

0920-9964

Publication Date

September 1995

Volume

17

Issue

1

Start / End Page

123 / 129

Location

Netherlands

Related Subject Headings

  • Schizophrenic Psychology
  • Schizophrenia
  • Psychiatry
  • Nootropic Agents
  • Neuropsychological Tests
  • Humans
  • Cognition Disorders
  • Chronic Disease
  • Antipsychotic Agents
  • 3202 Clinical sciences